- Home
- RFI vs TKNO Comparison
RFI vs TKNO Comparison
Compare RFI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFI
- TKNO
- Stock Information
- Founded
- RFI 1992
- TKNO 1996
- Country
- RFI United States
- TKNO United States
- Employees
- RFI N/A
- TKNO N/A
- Industry
- RFI Investment Managers
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- RFI Finance
- TKNO Health Care
- Exchange
- RFI Nasdaq
- TKNO Nasdaq
- Market Cap
- RFI 323.2M
- TKNO 356.4M
- IPO Year
- RFI N/A
- TKNO 2021
- Fundamental
- Price
- RFI $12.03
- TKNO $5.18
- Analyst Decision
- RFI
- TKNO
- Analyst Count
- RFI 0
- TKNO 0
- Target Price
- RFI N/A
- TKNO N/A
- AVG Volume (30 Days)
- RFI 69.8K
- TKNO 387.8K
- Earning Date
- RFI 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- RFI 8.25%
- TKNO N/A
- EPS Growth
- RFI N/A
- TKNO N/A
- EPS
- RFI N/A
- TKNO N/A
- Revenue
- RFI N/A
- TKNO $38,250,000.00
- Revenue This Year
- RFI N/A
- TKNO $8.73
- Revenue Next Year
- RFI N/A
- TKNO $16.53
- P/E Ratio
- RFI N/A
- TKNO N/A
- Revenue Growth
- RFI N/A
- TKNO 3.79
- 52 Week Low
- RFI $9.62
- TKNO $3.16
- 52 Week High
- RFI $12.52
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- RFI 52.69
- TKNO 54.38
- Support Level
- RFI $11.86
- TKNO $4.04
- Resistance Level
- RFI $12.10
- TKNO $5.31
- Average True Range (ATR)
- RFI 0.11
- TKNO 0.33
- MACD
- RFI 0.01
- TKNO 0.10
- Stochastic Oscillator
- RFI 72.00
- TKNO 85.07
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.